GlassScriptPhysician profile
Anna Stork-Fury
NPI 1457309429
$3,672.63
in general payments reported to CMS, 2019-2025
25 companies · $410 in 2025
The $410 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $184 · 2021: $491 · 2022: $595 · 2023: $658 · 2024: $810 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,609 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.47 |
| Education | $268.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $907.28 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $448.22 | 2019-2024 | |
| Hologic Sales and Service, LLC | $434.76 | 2021-2025 | Thinprep 2000 Processor, Aptima, Coolseal Generator |
| Astellas Pharma US INC | $389.56 | 2023-2025 | Veozah, Myrbetriq |
| Agile Therapeutics, INC. | $276.98 | 2022-2023 | Twirla |
| Intuitive Surgical, INC. | $254.68 | 2024-2025 | |
| Allergan, INC. | $180.36 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $143.58 | 2021-2025 | |
| Medtronic, INC. | $129.20 | 2022-2025 | Truclear |
| Bayer Healthcare Pharmaceuticals INC. | $100.77 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $94.64 | 2023-2025 | Myfembree |
| Organon LLC | $72.90 | 2024-2025 | Nexplanon |
| Myovant Sciences INC. | $50.54 | 2021-2022 | |
| Minerva Surgical, INC | $29.63 | 2019-2025 | |
| Stryker Corporation | $29.03 | 2025 | 1788 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $17.50 | 2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $15.91 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $15.83 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.17 | 2023 | Seglentis |
| Virtus Pharmaceuticals LLC | $13.94 | 2021 | |
| Amgen INC. | $13.89 | 2023 | |
| Exact Sciences Corporation | $13.89 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $13.75 | 2025 | Slynd |
| Mission Pharmacal Company | $11.62 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Stork-Fury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.